Clinical Trial Update: Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS [Phase 1]

View source ↗

Summary

Phase 1 safety and immunogenicity study evaluating a DNA vaccine combined with a protein vaccine for HIV/AIDS has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• DNA vaccine + protein vaccine (HIV/AIDS)

Snippet

Sponsor: EuroVacc Foundation | Conditions: HIV/AIDS | Phase 1 | Status: COMPLETED